Product Code: ETC10709081 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Opioid Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Opioid Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Opioid Market - Industry Life Cycle |
3.4 Mexico Opioid Market - Porter's Five Forces |
3.5 Mexico Opioid Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Mexico Opioid Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Mexico Opioid Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Mexico Opioid Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Mexico Opioid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Mexico |
4.2.2 Growing awareness and acceptance of opioid-based treatments |
4.2.3 Rising healthcare expenditure and improving access to healthcare facilities |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies related to opioid prescriptions and usage |
4.3.2 Concerns about opioid addiction and abuse in the population |
5 Mexico Opioid Market Trends |
6 Mexico Opioid Market, By Types |
6.1 Mexico Opioid Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Opioid Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Mexico Opioid Market Revenues & Volume, By Natural Opioids, 2021 - 2031F |
6.1.4 Mexico Opioid Market Revenues & Volume, By Semi-Synthetic Opioids, 2021 - 2031F |
6.1.5 Mexico Opioid Market Revenues & Volume, By Synthetic Opioids, 2021 - 2031F |
6.1.6 Mexico Opioid Market Revenues & Volume, By Combination Formulations, 2021 - 2031F |
6.2 Mexico Opioid Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mexico Opioid Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Mexico Opioid Market Revenues & Volume, By Anesthesia, 2021 - 2031F |
6.2.4 Mexico Opioid Market Revenues & Volume, By Cough Suppression, 2021 - 2031F |
6.2.5 Mexico Opioid Market Revenues & Volume, By Opioid Dependence Treatment, 2021 - 2031F |
6.3 Mexico Opioid Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Mexico Opioid Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Mexico Opioid Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Mexico Opioid Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.3.5 Mexico Opioid Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Mexico Opioid Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico Opioid Market Revenues & Volume, By Chronic Pain Patients, 2021 - 2031F |
6.4.3 Mexico Opioid Market Revenues & Volume, By Surgical Patients, 2021 - 2031F |
6.4.4 Mexico Opioid Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.4.5 Mexico Opioid Market Revenues & Volume, By Rehabilitation Centers, 2021 - 2031F |
7 Mexico Opioid Market Import-Export Trade Statistics |
7.1 Mexico Opioid Market Export to Major Countries |
7.2 Mexico Opioid Market Imports from Major Countries |
8 Mexico Opioid Market Key Performance Indicators |
8.1 Number of opioid prescriptions filled |
8.2 Percentage of healthcare providers trained in safe opioid prescribing practices |
8.3 Rate of opioid-related hospitalizations and emergency room visits |
9 Mexico Opioid Market - Opportunity Assessment |
9.1 Mexico Opioid Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Mexico Opioid Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Mexico Opioid Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Mexico Opioid Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Mexico Opioid Market - Competitive Landscape |
10.1 Mexico Opioid Market Revenue Share, By Companies, 2024 |
10.2 Mexico Opioid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |